It looks like you're accessing our website from North America. We have a dedicated page tailored to your region, offering the most relevant information and services.
If you have an existing eCom account, you can log in to the North American site using your current username and password.
Would you like to visit the North America page?
You can access the page here
If you have any questions, please feel free to contact our support team hytest@hytest.fi
We have developed three new monoclonal antibodies specific to BNP. BNP is an established cardiac biomarker and it is used as a diagnostic and prognostic marker of heart failure. Heart failure is a severe health problem that is characterized by an increasing prevalence and economic cost.
We now provide eight MAbs specific to BNP (see Figure 1).
Figure 1.
The new MAbs, 100cc, 130cc and 429cc can be used in combination with our other anti-BNP MAbs. Recommended MAb pairs for conventional BNP immunoassays are provided in Table 1.
Table 1.
MAb combination 57H3-429 and 50E1-130 show good correlation with commercially available assays (see Figure 2).
Figure 2.
More details of our product offering and data on their performance is available in the updated Human proBNP, BNP and NT-proBNP TechNotes.
Read the updated Human proBNP, BNP and NT-proBNP TechNotes
Copyright © 2025 Hytest Ltd.